NDC properties for NDC 9 0143-9375
NDC item 00143937501
NDC 9 | 0143-9375 |
---|---|
NDC 10 | 0143-9375-01 |
NDC Item | 00143937501 |
packaging | 1 mL in 1 VIAL |
ANDA | ANDA078630 |
FDA SPL set id | 651710 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-05-20 |
Marketing status | ACTIVE |
NDC item 00143937510
NDC 9 | 0143-9375 |
---|---|
NDC 10 | 0143-9375-10 |
NDC Item | 00143937510 |
packaging | 10 VIAL in 1 CARTON (0143-9375-10) / 1 mL in 1 VIAL (0143-9375-01) |
ANDA | ANDA078630 |
FDA SPL set id | 651710 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-05-20 |
Marketing status | ACTIVE |
NDC item 00143974601
NDC 9 | 0143-9746 |
---|---|
NDC 10 | 0143-9746-01 |
NDC Item | 00143974601 |
packaging | 1 mL in 1 VIAL |
ANDA | ANDA078630 |
FDA SPL set id | 760353 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-05-20 |
Marketing status | ACTIVE |
NDC item 00143974610
NDC 9 | 0143-9746 |
---|---|
NDC 10 | 0143-9746-10 |
NDC Item | 00143974610 |
packaging | 10 VIAL in 1 CARTON (0143-9746-10) / 1 mL in 1 VIAL (0143-9746-01) |
ANDA | ANDA078630 |
FDA SPL set id | 760353 |
Labeler | Hikma Pharmaceuticals USA Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-05-20 |
Marketing status | ACTIVE |
NDC item 00404996201
NDC 9 | 0404-9962 |
---|---|
NDC 10 | 0404-9962-01 |
NDC Item | 00404996201 |
packaging | 1 VIAL in 1 BAG (0404-9962-01) / 1 mL in 1 VIAL |
ANDA | ANDA076887 |
FDA SPL set id | 818961 |
Labeler | Henry Schein, Inc. |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2022-01-12 |
Marketing status | ACTIVE |
NDC item 55390010110
NDC 9 | 55390-101 |
---|---|
NDC 10 | 55390-101-10 |
NDC Item | 55390010110 |
packaging | 10 VIAL in 1 BOX (55390-101-10) / 1 mL in 1 VIAL |
ANDA | ANDA076770 |
FDA SPL set id | 17160 |
Labeler | Bedford Laboratories |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2011-12-31 |
Marketing effective time low | 2004-04-28 |
Marketing status | COMPLETED |
NDC item 59923061501
NDC 9 | 59923-615 |
---|---|
NDC 10 | 59923-615-01 |
NDC Item | 59923061501 |
packaging | 1 mL in 1 VIAL, SINGLE-USE |
ANDA | ANDA200122 |
FDA SPL set id | 814720 |
Labeler | Areva Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-10-04 |
Marketing status | active |
NDC item 59923061505
NDC 9 | 59923-615 |
---|---|
NDC 10 | 59923-615-05 |
NDC Item | 59923061505 |
packaging | 5 VIAL, SINGLE-USE in 1 CARTON (59923-615-05) / 1 mL in 1 VIAL, SINGLE-USE (59923-615-01) |
ANDA | ANDA200122 |
FDA SPL set id | 814720 |
Labeler | Areva Pharmaceuticals |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2024-10-04 |
Marketing status | active |
NDC item 63323066500
NDC 9 | 63323-665 |
---|---|
NDC 10 | 63323-665-00 |
NDC Item | 63323066500 |
packaging | 1 mL in 1 VIAL, SINGLE-USE |
ANDA | ANDA076887 |
FDA SPL set id | 650769 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-03-10 |
Marketing status | ACTIVE |
NDC item 63323066501
NDC 9 | 63323-665 |
---|---|
NDC 10 | 63323-665-01 |
NDC Item | 63323066501 |
packaging | 25 VIAL, SINGLE-USE in 1 TRAY (63323-665-01) / 1 mL in 1 VIAL, SINGLE-USE (63323-665-00) |
ANDA | ANDA076887 |
FDA SPL set id | 650769 |
Labeler | Fresenius Kabi USA, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2011-03-10 |
Marketing status | ACTIVE |
NDC item 70860080101
NDC 9 | 70860-801 |
---|---|
NDC 10 | 70860-801-01 |
NDC Item | 70860080101 |
packaging | 10 VIAL in 1 CARTON (70860-801-01) / 1 mL in 1 VIAL (70860-801-41) |
ANDA | ANDA200122 |
FDA SPL set id | 353618 |
Labeler | Athenex Pharmaceutical Division, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-08-31 |
Marketing effective time low | 2017-02-22 |
Marketing status | COMPLETED |
NDC item 70860080141
NDC 9 | 70860-801 |
---|---|
NDC 10 | 70860-801-41 |
NDC Item | 70860080141 |
packaging | 1 mL in 1 VIAL |
ANDA | ANDA200122 |
FDA SPL set id | 353618 |
Labeler | Athenex Pharmaceutical Division, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time high | 2020-08-31 |
Marketing effective time low | 2017-02-22 |
Marketing status | COMPLETED |
NDC item 71872708001
NDC 9 | 71872-7080 |
---|---|
NDC 10 | 71872-7080-1 |
NDC Item | 71872708001 |
packaging | 1 VIAL in 1 BAG (71872-7080-1) / 1 mL in 1 VIAL |
ANDA | ANDA078630 |
FDA SPL set id | 711465 |
Labeler | Medical Purchasing Solutions. LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2009-05-20 |
Marketing status | ACTIVE |
NDC item 71872713001
NDC 9 | 71872-7130 |
---|---|
NDC 10 | 71872-7130-1 |
NDC Item | 71872713001 |
packaging | 1 VIAL in 1 BAG (71872-7130-1) / 1 mL in 1 VIAL |
ANDA | ANDA200122 |
FDA SPL set id | 448756 |
Labeler | Medical Purchasing Solutions, LLC |
Label type | HUMAN PRESCRIPTION DRUG |
Marketing category | ANDA |
Marketing effective time low | 2017-02-22 |
Marketing status | ACTIVE |